[Federal Register Volume 84, Number 37 (Monday, February 25, 2019)]
[Notices]
[Page 6012]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-03184]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Council on Blood Stem Cell 
Transplantation

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act (FACA), 
this notice announces that the Secretary's Advisory Council on Blood 
Stem Cell Transplantation (ACBSCT) has scheduled a public meeting. 
Information about ACBSCT and the agenda for this meeting can be found 
on the ACBSCT website at https://bloodcell.transplant.hrsa.gov/about/advisory_council/meetings/index.html.

DATES: May 7, 2019, 10:00 a.m.-4:00 p.m. Eastern Time.

ADDRESSES: This meeting will be held by webinar. Members of the public 
can access the webinar link and conference call-in number at https://www.organdonor.gov/about-dot/acot.html.

FOR FURTHER INFORMATION CONTACT: Robert Walsh, Designated Federal 
Official, (DFO), at Healthcare Systems Bureau, Division of 
Transplantation, HRSA, 5600 Fishers Lane, 8W60, Rockville, Maryland 
20857; 301-443-6839; or [email protected].

SUPPLEMENTARY INFORMATION: ACBSCT provides advice and recommendations 
to the Secretary of HHS and the HRSA Administrator on the activities of 
the C.W. Bill Young Cell Transplantation Program (CWBYCTP) and the 
National Cord Blood Inventory (NCBI) Program. The principal purpose of 
these programs is to make blood stem cells from adult donors and cord 
blood units available for patients who need a transplant to treat life-
threatening conditions such as leukemia, and who lack a suitably 
matched relative who can be the donor.
    During the May 7, 2019, meeting, members of ACBSCT will discuss 
issues related utilization of cord blood for transplant and utilization 
of blood stem cells in cellular therapies. Agenda items are subject to 
change as priorities dictate. Refer to the ACBSCT website for any 
updated information concerning the meeting.
    Members of the public will have the opportunity to provide 
comments. Public participants may submit written statements in advance 
of the scheduled meeting. Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to ACBSCT should be 
sent to Robert Walsh, DFO, using the contact information above at least 
three business days before the meeting.
    Individuals who plan to participate in the webinar and need special 
assistance or other reasonable accommodations should notify Robert 
Walsh at the address and phone number listed above at least 10 business 
days before the meeting.

Amy P. McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2019-03184 Filed 2-22-19; 8:45 am]
BILLING CODE 4165-15-P